The investigation of the antipsychotic effects of adding d-penicillamine to risperidone on schizophrenia.
Not Applicable
- Conditions
- ?????????schizophrenia.
- Registration Number
- IRCT20131007014928N6
- Lead Sponsor
- Mazandaran University of Medical Science.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patient with schizophrenia that did not receive any antipsychotics during the last week.
Exclusion Criteria
Patient did not suffer from Wilson's or other metabolic diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive and negative symptoms. Timepoint: weekly. Method of measurement: PANSS.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: weekly until 6 weeks. Method of measurement: Simpson Angus Scale.